Important information on minimizing the risk of aortic aneurysm and dissection and cardiac valve regurgitation/insufficiency with the use of systemic and inhaled fluoroquinolones

26.12.2022 1237 views

Важлива інформація з мінімізації ризику аневризми і дисекції аорти та регургітації/недостатності серцевого клапана при застосуванні системних та інгаляційних фторхінолонівPDF · 296 КБ

Завантажити

Important information on minimizing the risk of aortic aneurysm and dissection and cardiac valve regurgitation/insufficiency with the use of systemic and inhaled fluoroquinolones

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Important information on minimizing the risk of aortic aneurysm and dissection and cardiac valve regurgitation/insufficiency with the use of systemic and inhaled fluoroquinolones

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration